tl;dr
Pediatricians are cautious about prescribing Wegovy and similar weight loss drugs to teenagers, despite their potential effectiveness, due to concerns over safety and long-term impacts.Link to original article
https://www.nytimes.com/2023/12/11/health/teens-wegovy-obesity-drugs-ozempic.htmltl;dr bits
- 22% of adolescents have obesity, with severe cases leading to diabetes, heart disease, and other health issues.
- Pediatricians are hesitant to prescribe new weight loss drugs like Wegovy due to concerns about long-term effects and lack of familiarity.
- Obesity is recognized as a chronic disease, not just a matter of willpower.
If only hesitation didn't weigh so heavily on young patients.
Condensed 600+ words into 85 words
Comments